Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
Sabatine, Marc S, Dr, Antman, Elliott M, Prof, Widimsky, Petr, Prof, Ebrahim, Iftikhar O, MBBCh, Kiss, Robert G, MD, Saaiman, André, MD, Polasek, Rostislav, MD, Contant, Charles F, PhD, McCabe, Carolyn H, BS, Braunwald, Eugene, Prof
Published in The Lancet (British edition) (05.09.2009)
Published in The Lancet (British edition) (05.09.2009)
Get full text
Journal Article
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy
Hochholzer, Willibald, MD, Trenk, Dietmar, PhD, Mega, Jessica L., MD, MPH, Morath, Tanja, MD, Stratz, Christian, MD, Valina, Christian M., MD, O'Donoghue, Michelle L., MD, Bernlochner, Isabell, MD, Contant, Charles F., PhD, Guo, Jianping, MAS, Sabatine, Marc S., MD, MPH, Schömig, Albert, MD, Neumann, Franz-Josef, MD, Kastrati, Adnan, MD, Wiviott, Stephen D., MD, Sibbing, Dirk, MD
Published in The American heart journal (01.09.2011)
Published in The American heart journal (01.09.2011)
Get full text
Journal Article
Efficacy and Safety of a Potent and Selective Peroxisome Proliferator Activated Receptor Alpha Agonist in Subjects With Dyslipidemia and Type 2 Diabetes Mellitus
Terra, Steven G., PharmD, Francone, Omar L., PhD, Contant, Charles F., PhD, Gao, Xiang, PhD, Lewin, Andrew J., MD, Nguyen, Tu T., MD
Published in The American journal of cardiology (15.08.2008)
Published in The American journal of cardiology (15.08.2008)
Get full text
Journal Article